There is still a great deal of excitement in this field.
Their data are certainly very good . . . and quite significant, ... is problematic.
We could have made tremendous progress in getting these cells toward clinical application if federal funding had been available.
Although it hurts, I think we have to say that if there is fraud of any kind ... it has to be exposed, no matter what the cost. The truth is of more value than anything else.
These cells will rapidly let us study human processes in a way we couldn't before.
I think we have to keep our eye on the ball here. If this stuff proves to work, that's wonderful. But we're just not there yet, and it's going to take a long time to demonstrate that. Meanwhile, other techniques already work well. So let's get on with it.
Regardless of all the strife in this field and our complaining incessantly about national policy, and despite some recent events that have cast a shadow on this work, there's a great deal of excitement in this field.
He took the title of senior author but really didn't know what was going on with the data.
Should reviewers have caught some of this? Yeah, probably they should have. Obviously great claims require great proof, and maybe more people should review such a paper.
Clearly the scientific credibility of Korean investigators has been compromised.
